Found: 20
Select item for more details and to access through your institution.
Complementary Medicine Use Amongst Patients with Metastatic Cancer Enrolled in Phase III Clinical Trials.
- Published in:
- Oncologist, 2022, v. 27, n. 3, p. e286, doi. 10.1093/oncolo/oyac020
- By:
- Publication type:
- Article
Non-Exonuclease Domain POLE Mutations Associated with Immunotherapy Benefit.
- Published in:
- Oncologist, 2022, v. 27, n. 3, p. 159, doi. 10.1093/oncolo/oyac017
- By:
- Publication type:
- Article
Liquid Biopsy-based Precision Therapy in Patients with Advanced Solid Tumors: A Real-world Experience from a Community-based Oncology Practice.
- Published in:
- Oncologist, 2022, v. 27, n. 3, p. 183, doi. 10.1093/oncolo/oyac007
- By:
- Publication type:
- Article
Real-world Treatment Patterns and Reasons for Therapy Selection in Patients with Advanced Hepatocellular Carcinoma in US Oncology Practices.
- Published in:
- Oncologist, 2022, v. 27, n. 3, p. e265, doi. 10.1093/oncolo/oyab059
- By:
- Publication type:
- Article
Impact of Immune Checkpoint Inhibitors on COVID-19 Severity in Patients with Cancer.
- Published in:
- Oncologist, 2022, v. 27, n. 3, p. 236, doi. 10.1093/oncolo/oyab083
- By:
- Publication type:
- Article
Phase II Study of Pembrolizumab in Combination with Capecitabine and Oxaliplatin with Molecular Profiling in Patients with Advanced Biliary Tract Carcinoma.
- Published in:
- Oncologist, 2022, v. 27, n. 3, p. e273, doi. 10.1093/oncolo/oyab073
- By:
- Publication type:
- Article
Discordance in Tumor Mutation Burden from Blood and Tissue Affects Association with Response to Immune Checkpoint Inhibition in Real-World Settings.
- Published in:
- Oncologist, 2022, v. 27, n. 3, p. 175, doi. 10.1093/oncolo/oyab064
- By:
- Publication type:
- Article
Impact of the Economic Status of the Patient's Country of Residence on the Outcome of Oncology Clinical Trials.
- Published in:
- Oncologist, 2022, v. 27, n. 3, p. e244, doi. 10.1093/oncolo/oyab060
- By:
- Publication type:
- Article
Management of Dermatologic Events Associated With the Nectin-4-directed Antibody-Drug Conjugate Enfortumab Vedotin.
- Published in:
- Oncologist, 2022, v. 27, n. 3, p. e223, doi. 10.1093/oncolo/oyac001
- By:
- Publication type:
- Article
Treatment Patterns, Health Care Resource Utilization, and Cost in Patients with Myelofibrosis in the United States.
- Published in:
- Oncologist, 2022, v. 27, n. 3, p. 228, doi. 10.1093/oncolo/oyab058
- By:
- Publication type:
- Article
Multi-institutional Analysis of the Clinical and Genomic Characteristics of Black Patients with Metastatic Hormone-Sensitive Prostate Cancer.
- Published in:
- Oncologist, 2022, v. 27, n. 3, p. 220, doi. 10.1093/oncolo/oyab057
- By:
- Publication type:
- Article
BRAF Mutations Are Associated with Poor Survival Outcomes in Advanced-stage Mismatch Repair-deficient/Microsatellite High Colorectal Cancer.
- Published in:
- Oncologist, 2022, v. 27, n. 3, p. 191, doi. 10.1093/oncolo/oyab055
- By:
- Publication type:
- Article
Impact of Breast Cancer Treatment Delays on Survival Among South African Women.
- Published in:
- Oncologist, 2022, v. 27, n. 3, p. e233, doi. 10.1093/oncolo/oyab054
- By:
- Publication type:
- Article
Homologous Recombination Deficiency: Concepts, Definitions, and Assays.
- Published in:
- Oncologist, 2022, v. 27, n. 3, p. 167, doi. 10.1093/oncolo/oyab053
- By:
- Publication type:
- Article
Perspectives of Young Women With Gynecologic Cancers on Fertility and Fertility Preservation: A Systematic Review.
- Published in:
- Oncologist, 2022, v. 27, n. 3, p. e251, doi. 10.1093/oncolo/oyab051
- By:
- Publication type:
- Article
Sorafenib in Dupuytren and Ledderhose Disease.
- Published in:
- Oncologist, 2022, v. 27, n. 3, p. e294, doi. 10.1093/oncolo/oyab050
- By:
- Publication type:
- Article
Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2022, v. 27, n. 3, p. 198, doi. 10.1093/oncolo/oyab046
- By:
- Publication type:
- Article
Adoptive T-Cell Therapy in Advanced Colorectal Cancer: A Systematic Review.
- Published in:
- Oncologist, 2022, v. 27, n. 3, p. 210, doi. 10.1093/oncolo/oyab038
- By:
- Publication type:
- Article
Phase I Study Evaluating Dose De-escalation of Sorafenib with Metformin and Atorvastatin in Hepatocellular Carcinoma (SMASH).
- Published in:
- Oncologist, 2022, v. 27, n. 3, p. 165, doi. 10.1093/oncolo/oyab008
- By:
- Publication type:
- Article
Phase I Trial of a Third Generation EGFR Mutant-Selective Inhibitor (D-0316) in Patients with Advanced Non-Small Cell Lung Cancer.
- Published in:
- Oncologist, 2022, v. 27, n. 3, p. 163, doi. 10.1093/oncolo/oyab007
- By:
- Publication type:
- Article